Back to Rankings

TRVI

Trevi TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
TRVI vs peer average
52/100
TRVI vs. peer average (D vs. D)
Grade spread
B 2 · D 3 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

VYGR is the first available peer comparator.

Biotech with CNS and orphan programs; subject to similar regulatory and trial-readout catalysts.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerVYGRVoyager Therapeutics
TRVI
Trevi Therapeutics
VYGR
Voyager Therapeutics
Grade
D
F
Momentum
82
31
Value
41
41
Sentiment
0
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs VYGR

TRVI / VYGR
Grade Position
In line
TRVI vs. peer average (D vs. D)
52/100
Momentum
82
TRVI
Value
41
TRVI
Sentiment
0
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs TRVI
1
VYGR
VYGR
F
20/100
+1
2
CLNN
CLNN
F
20/100
+1
3
RXRX
Recursion Pharmaceuticals Inc Class A Common
F
20/100
+1
4
MESO
Mesoblast Ltd ADR
F
20/100
+1
5
BHC
Bausch Health Companies Inc Common
D
40/100
Even
VYGR is the first peer returned for this comparison set.